Many of the artificial hip devices in question failed after only several years of use, despite having an expected life of 10 to 20 years. The ASR XL hip devices were manufactured by DePuy Synthes, a subsidiary of J&J. J&J disclosed that federal prosecutors have requested documents regarding possible false claims made to federal healthcare programs by its subsidiary.

California’s attorney general is leading another probe into J&J’s marketing practices regarding its Gynecare Prolift vaginal mesh implant. The investigation is looking into the improper marketing of the surgical mesh for urogynecological and hernia uses.

J&J faces over 10,000 pending lawsuits related to the ASR XL hip device and over 1,800 lawsuits related to its surgical mesh implant. J&J has denied any negligence but has set aside over $1 billion to cover legal and recall expenses.

Johnson & Johnson shares fell 1 cent to close at $76.25 on Friday.

Don’t Miss: Royalty Pharma Puts In $6.6 Billion Bid for Elan.